Transaction in Own Shares
Summary by AI BETAClose X
22 October 2026
River UK Micro Cap Limited
Transaction in Own Shares
Further to the confirmation of its intention to continue the share buyback programme, as set out in its announcement on 15 September 2026, the Company announces that on 21 October 2026 it purchased a total of 20,000 of its ordinary shares of no-par value each ("Ordinary Shares") at a price of 259.4 pence per Ordinary Share through Singer Capital Markets. The Ordinary Shares purchased will be held in treasury.
Aggregated information
|
Date of purchase |
21 October 2026 |
|
Number of Ordinary Shares purchased |
20,000 |
|
Highest price paid per Ordinary Share |
259.4 p |
|
Lowest price paid per Ordinary Share |
259.4 p |
|
Volume weighted average price paid per Ordinary Share |
259.4 p |
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018), a detailed breakdown of individual trades is available below:
|
Number of Ordinary Shares purchased |
Transaction price (GBP) |
Time of transaction |
Trading venue |
|
20,000 |
2.594 |
16:13:35 |
XLON |
Total voting rights
Following the purchase, the Company's total issued share capital will consist of 33,897,954 Ordinary Shares each carrying one voting right, of which 1,988,051 Ordinary Shares are held in treasury. Therefore, the total number of Ordinary Shares carrying voting rights is 31,909,903. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
- ENDS -
LEI: 21380061WNNSD9RGUH84
For further information please contact:
|
Liontrust Investments LLP |
|
|
Lucy Draper |
Lucy.Draper@liontrust.com Tel: +44 7702 799 117 |
|
|
|
|
|
|
|
|
|
|
Singer Capital Markets |
|
|
James Moat, Investment Banking |
Tel: +44 20 7496 3000 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 2 hours ago Frasers Group
- 2 hours ago Cavendish Financial
- 2 hours ago Diaceutics
- 2 hours ago AB Dynamics
- 15 hours ago Johnson Matthey